Search Browse Earnings

Terns Pharmaceuticals, Inc.

Nasdaq:TERN

Pharmaceutical Preparations·FOSTER CITY, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$1.0M

FY 2022

Adj. EBITDA

-$102.3M

-10226.6% margin

FY 2024

Net Income

-$90.2M

-9021.0% margin

FY 2024

EPS (Diluted)

-$1.27

FY 2024

Stock Price

$52.92

+0.1%

2026-03-27

52W Range

$1.86 – $53.19

P/E Ratio

-41.7x

Market Cap

$4.8B

Cash

$79.9M

FY 2024

Total Debt

—

Net Cash

$79.9M

FY 2023

Enterprise Value

$4.7B

Debt / EBITDA

0.8x

FY 2022

EV / EBITDA

-45.8x

Employees

—